HCAT
Health Catalyst, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.33
P/S
0.27
EV/EBITDA
14.27
DCF Value
$16.24
FCF Yield
-5.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.5%
Operating Margin
-11.6%
Net Margin
-57.2%
ROE
-54.7%
ROA
-35.4%
ROIC
-8.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $74.7M | $-91.0M | $-1.28 |
| FY 2025 | $311.1M | $-178.0M | $-2.55 |
| Q3 2025 | $76.3M | $-22.2M | $-0.32 |
| Q2 2025 | $80.7M | $-41.0M | $-0.59 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.81
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.